CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Weight Lossbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03342742
NCT03342742N/ACompleted
CompareCT.gov

Daily Caloric Restriction and Intermittent Fasting in Overweight and Obese Adults With Autosomal Dominant Polycystic Kidney Disease

University of Colorado, Denver·interventional·Posted Nov 17, 2017·Updated Mar 3, 2022

In Brief

A clinical study evaluating Weight Loss for Polycystic Kidney, Autosomal Dominant. Completed, enrolled 29 participants across 1 site.

Detailed Summary

The proposed research will determine the feasibility of delivering two behavioral weight loss interventions for 1 year in adults with autosomal dominant polycystic kidney disease (ADPKD) who are overweight or obese. The study will also compare these two interventions in terms of safety, acceptability, and tolerability. Last, this pilot trial will provide initial insight into a) biological changes and b) changes in kidney growth with each of the two weight loss interventions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Kidney, Autosomal Dominant
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 17, 2017
Enrollment StartJun 4, 2018
Primary CompletionOct 13, 2020
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 8.6 years ago

Interventions

Weight Lossbehavioral

Weight loss behavioral intervention via one of two strategies.